Callan Capital was listed in the San Diego Business Journal’s inaugural Life Sciences Book as a key service provider to the Life Sciences industry. The article mentions how Callan Capital deals with the Life Sciences industry’s frequent liquidity events, such as selling a company or taking a company public. In addition, the firm has experience in the nuances of the sector, such as how to work within the limited and infrequent windows for exercising stock options because of potential issues with insider trading related to clinical trials, partnership deals and acquisitions.
Callan Capital is proud to serve San Diego’s Life Sciences executives and entrepreneurs and excited to be recognized as the sole wealth management firm listed in the Life Sciences book. To read the article, click here.